Loading...

Quantum-Si incorporated

QSINASDAQ
Healthcare
Biotechnology
$1.96
$0.00(0.00%)

Quantum-Si incorporated (QSI) Stock Overview

Explore Quantum-Si incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.5/100

Key Financials

Market Cap348.6M
P/E Ratio-3.48
EPS (TTM)$-0.68
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Week$1.95
1 Month$1.18
3 Months$1.30
1 Year Target$0.54

QSI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quantum-Si incorporated (QSI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.48 and a market capitalization of 348.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
182.62%
182.62%
Profit Growth
$-0.55
5.26%
EPS Growth
$-0.55
4.41%
Operating Margin
-3204.41%
2.33%
ROE
-44.46%
5.26%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$3.65
Average$3.65
High$3.65

Company Profile

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

CEO

Jeffrey Alan Hawkins

Employees

149

Headquarters

530 Old Whitfield Street, Guilford, CT

Founded

2020

Frequently Asked Questions

;